SEC declares Chemomab-Scipher merger registration effective; shareholder vote set for Dec 4

Chemomab Therapeutics says the SEC declared its merger registration with Scipher Medicine effective. A shareholder vote on the merger is set for December 4.

Detected & updated continuously · Source: Nebula

Story subjects

Chemomab Therapeutics Ltd.Scipher MedicineU.S. Securities and Exchange Commission

Track sentiment and mindshare across stocks and crypto in Nebula.

Open Nebula